Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR2 | P30874 | 15/20 | 0.83 |
| ▸ | SSTR5 | P35346 | 12/20 | 0.83 |
| ▸ | SSTR4 | P31391 | 10/20 | 0.83 |
| ▸ | SSTR3 | P32745 | 3/20 | 0.77 |
| ▸ | SSTR1 | P30872 | 3/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23901126 | 0.94 | SSTR2 (0.88) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL23482744 | 0.93 | SSTR2 (0.88) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL22388803 | 0.93 | SSTR2 (0.87) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL22389054 | 0.93 | SSTR2 (0.87) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL25504914 | 0.93 | SSTR2 (0.87) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL25032557 | 0.91 | SSTR2 (0.86) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Octreotide SCHEMBL21944070 | 0.91 | SSTR2 (1.00) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Octreotide SCHEMBL17404705 | 0.91 | SSTR2 (1.00) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Octreotide SCHEMBL23424109 | 0.91 | SSTR2 (1.00) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Octreotide SCHEMBL21840389 | 0.91 | SSTR2 (1.00) | SSTR2SSTR5SSTR4SSTR3SSTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210369855-A1 | CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2021-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210369855-A1 | CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE | CD4, MCL1, CCNB1 | SSTR2 3329/4885SSTR5 3594/4885SSTR4 3559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.